Our Researchers | Leukaemia Foundation

All posts in Our researchers

Developing new treatments for Burkitt’s lymphoma

The Leukaemia Foundation is funding research aimed at advancing treatment for a blood cancer called Burkitt’s lymphoma (BL), thanks to the generous support of a major donor who has survived this aggressive blood cancer.  There is a need for alternative therapies for people with BL, according to Dr Gemma Kelly, a senior postdoctoral research scientist at the Walter and Eliza Hall Institute (Melbourne).  Dr Kelly and Professor […]

The only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life.

Reshaping our thinking on blood cancer treatment

Researchers at Monash University have discovered a key reason why a type of blood cancer called acute myeloid leukaemia (AML) is such a difficult disease to treat and cure. More than 1,000 Australians are told they have AML each year but less than a third of them will be alive five years after their diagnosis. […]

The only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life.
Dr Ken Micklethwaite

Australian study first ever to use CAR T-cells to prevent relapse after treatment

In a world first, the Australian COMMITTAL trial uses CAR T-cell therapy to improve survival for people with B-cell ALL who have an allogeneic stem cell transplantation (SCT). Dr Ken Micklethwaite, a clinical haematologist and bone marrow physician, who runs the CAR T-cell program at The Westmead Institute of Medical Research (Sydney), describes the study […]

The only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life.

Brightest blood cancer minds come to Queensland

Some of Australia’s leading blood cancer researchers came to Brisbane earlier this year to share fascinating insights and knowledge that will help the state’s researchers beat blood cancer. Thanks to our supporters, we were able to help bring Professor Fabienne Mackay from the University of Melbourne and Associate Professor John Pimanda from the University of New South […]

The only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life.

Improving lymphoma outcomes with personal touch

A recent review of the latest medical advances for people with Hodgkin lymphoma has highlighted how personalised treatment is improving outcomes for patients. Professor Maher Gandhi, the Leukaemia Foundation Chair in Blood Cancer Research at The University of Queensland’s Diamantina Institute, said the new approaches were aimed at “minimising toxicity while maximising response”. He said […]

The only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life.

Research highlights the costs of relocating for cancer treatment

The heavy costs associated with relocating to the city for blood cancer treatment have been revealed in new research funded with the help of our generous supporters. Associate Professor Pam McGrath, from the Centre for Community Science at Griffith University, said the financial burden of getting to treatment was not well-known and was especially critical […]

The only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life.

Examining the link between Down syndrome and blood cancer

People with Down syndrome have a heightened risk of developing a blood cancer or disorder, with research indicating an extra copy of a blood cell development gene might be responsible. The role of the gene, called the Erg gene, in predisposing to Down syndrome blood disorders is being examined by Dr Ashley Ng, a researcher at the […]

The only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life.

Targeting cancer ‘survival’ protein to kill cancer cells

A protein critical for the survival of many cancer cells, called MCL-1, might be the key to a new treatment for lymphoma and leukaemia patients. Leukaemia Foundation funded researcher Dr Stephanie Grabow and her team, in particular Drs Gemma Kelly and Brandon Aubrey at Melbourne’s Walter and Eliza Hall Institute of Medical Research, are investigating the […]

The only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life.

Unravelling the genetic mysteries of myeloma

Despite being the third most common blood cancer affecting more than 1500 Australians each year, mystery surrounds the development of myeloma. What we do know is that in almost every case, myeloma develops from a benign (non-cancerous) disease known as monoclonal gammopathy of undetermined significance (MGUS). We just don’t know how. Looking at the genes […]

The only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life.

Working to understand and improve MDS drug

Azacitidine (Vidaza®) is the only drug available for treating myelodysplastic syndrome (MDS), and is also used to treat several other blood cancers. Unfortunately, the drug is only effective in about half of MDS cases, and its exact mode of action isn’t understood. With funding support from the Leukaemia Foundation, Dean Tyler at the University of Melbourne and Peter […]

The only national charity dedicated to helping those with leukaemia, lymphoma, myeloma and related blood disorders survive and then live a better quality of life.
X
X